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The Grand Challenge for Sleep and Chronobiology in the Neurology/Neuroscience domains for 
the twenty-first century is to improve our understanding of the complex relationships between 
sleep, wake, and chronobiology in healthy subjects and in patients with neurological disorders.
Sleep disorders are very common and often disabling conditions that can be isolated or 
associated with neurological disorders. In addition to neurologists and neurophysiologists, pul-
monologists, psychiatrists, cardiologists, pediatricians, ENT doctors, psychologists, geneticists, and 
basic scientists also are involved in sleep disorder diagnosis and research. This corresponds to a 
heterogeneous group of physicians/researchers with different interests and expertise that include 
basic and clinically applied research. Our diversity of interests is both our strength and a challenge.
Sleep is a universal physiological need that plays a key role in the prevention of health problems. 
In modern life, sleep disruption through behavioral deprivation is a major issue. Indeed, one-third 
of the population is affected by sleep disorders, as defined by the revised International Classification 
of Sleep Disorders (1), namely insomnia, central hypersomnolence disorders (such as narcolepsy), 
sleep-related movements disorders (such as restless legs syndrome), sleep-related breathing disor-
ders, parasomnias (such as sleepwalking and REM-sleep behavior disorder), and circadian rhythm 
sleep–wake disorders. Epidemiological studies have demonstrated the large prevalence of many 
sleep disorders in the general population, especially in patients with neurological and psychiatric 
diseases, and their association with a decline of cognitive performance, productivity, and quality 
of life, with a major social, medical, and economic impact. People with sleep disorders are often 
at risk of accidents, psychiatric, neurological and cardiovascular diseases, obesity, and metabolic 
disorders, for example, sleep-disordered breathing, excessive daytime sleepiness, short and long 
sleeping time are risk factors for cardiovascular diseases; insomnia for depression; REM-sleep 
behavior disorder for Parkinsonism, etc. In addition, sleep–wake alterations (e.g., reduced slow 
wave sleep and circadian disturbances) may influence the course and outcome of neurodegenerative 
diseases, such as Alzheimer’s disease (2).
Narcolepsy with cataplexy remains the classic example of neurological sleep disorder and one 
of the most studied sleep disorders at the molecular level. Narcolepsy is a disabling disorder char-
acterized by excessive daytime sleepiness and abnormal rapid-eye-movement sleep manifestations, 
including cataplexy (sudden loss of muscle tone triggered by strong emotions), sleep paralysis, 
hypnagogic hallucinations, and sleep onset REM periods (3). Narcolepsy with cataplexy has been 
renamed narcolepsy type 1 due to the deficiency in hypocretin signaling caused by the selective 
loss of hypothalamic hypocretin neurons. Conversely, no other specific reliable biomarker has been 
described so far for most of the other sleep disorders.
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Sleep and wakefulness are complex behaviors regulated at 
many different levels that are likely to be under strong environ-
mental, immune, and genetic control (4). In the past decades, 
clinical and translational studies on sleep and circadian systems 
provided exciting insights for the entire field of neurobiology, 
sleep–wake processing, regulation, and function. The combina-
tion of increased technical complexity and growing need of inter-
disciplinary research poses new challenges to our community 
with contributions from many scientific fields, such as neurosci-
ence, physiology, biology, genetic, epidemiology, psychology, 
and medicine. Thus, advances in translational research provide 
key opportunities to explore sleep physiological and pathologi-
cal effects in different neurological diseases. However, the great 
progress in our understanding of the physiological sleep–wake 
and circadian processes has only slightly modified our diagnostic 
procedures and management of sleep disorders (5).
We need to improve the diagnosis of sleep disorders for their 
early detection and better management and also for the identifi-
cation of sleep–wake alterations as risk factors of bad outcome 
of neurological conditions. The treatment of sleep disorders may 
have positive consequences on disease progression, for instance 
using continuous positive air pressure in patients with severe 
obstructive sleep disorders breathing. Further interventional 
studies are needed to determine whether treatment of sleep 
disorders might improve neurological disorders, prevent their 
development and progression, and whether their optimal man-
agement might improve sleep in these populations.
The Grand Challenges for Sleep and Chronobiology in 
Neurology/Neuroscience are to improve our understanding of 
sleep–wake and circadian regulation and function; to disseminate 
the knowledge on sleep and sleep disorders to pre- and post-
graduate physicians; and to educate neurologists and psychiatrists 
who, in the past, often neglected sleep as well as neuroscience 
researchers. Finally, we need to discover better treatment and to 
define up-to-date guidelines for the management of patients with 
primary or comorbid sleep disorders.
We hope that the Frontiers in Neurology “Sleep and 
Chronobiology” section will become one of the first choices for 
sleep-related publications by clinicians and researchers interested 
in this field. Our goals are to publish open-access high-quality 
research with rapid publication to advance our understanding of 
this large and complex discipline. We accept various manuscript 
types and strongly encourage submission of original articles.
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